Geron | GERN - Loan Capital


Geron reported $119.55M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Amgen USD 50B 2.43B Dec/2025
Bio Techne USD 260M 40M Dec/2025
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 1.12B 957.23M Dec/2025
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
Geron USD 119.55M 283K Dec/2025
Gilead Sciences USD 22.13B 6M Dec/2025
Incyte USD 30.2M 5.17M Dec/2025
MacroGenics USD 70M 256K Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Novavax USD 246.3M 200K Dec/2025